【打印本页】 【下载PDF全文】 【HTML】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 703次   下载 882 本文二维码信息
码上扫一扫!
慢性硬膜下血肿术后复发危险因素的研究进展
魏雁鹏1,唐海双2,左乔1,刘建民1*
0
(1. 海军军医大学(第二军医大学)第一附属医院脑血管病中心, 上海 200433;
2. 海军军医大学(第二军医大学)海军特色医学中心, 上海 200433
*通信作者)
摘要:
慢性硬膜下血肿(CSDH)是神经外科最常见疾病之一,随着人口老龄化和抗血栓药物的广泛使用,其发病率逐年上升。大部分CSDH患者通过手术治疗可获得较好的治疗效果,但仍有5%~30%的患者术后出现血肿复发需要再次入院治疗。CSDH术后复发的常见危险因素包括患者性别、年龄、基础疾病等自身因素,以及入院时血肿影像学形态、抗血栓药物的使用、麻醉方式、手术方式、辅助药物等。
关键词:  慢性硬膜下血肿  复发  危险因素  手术方式  药物
DOI:10.16781/j.CN31-2187/R.20220434
投稿时间:2022-05-21修订日期:2022-12-22
基金项目:海军军医大学(第二军医大学)第一附属医院“234学科攀峰计划”(2020YXK001),上海申康医院发展中心临床三年行动计划重大疾病多中心研究项目(SHDC2020CR1018B).
Risk factors of postoperative recurrence of chronic subdural hematoma: research progress
WEI Yan-peng1,TANG Hai-shuang2,ZUO Qiao1,LIU Jian-min1*
(1. Neurovascular Center, The First Affiliated Hospital of Naval Medical University (Second Military Medical University), Shanghai 200433, China;
2. Naval Medical Center, Naval Medical University (Second Military Medical University), Shanghai 200433, China
*Corresponding author)
Abstract:
Chronic subdural hematoma (CSDH) is one of the most common diseases in neurosurgery, and its incidence is increasing every year with the aging of the population and the widespread use of antithrombotic drugs. The majority of patients with CSDH have a good outcome with surgical treatment, but 5%-30% of patients still experience recurrence of hematoma and require readmission to the hospital. Common risk factors of hematoma recurrence include the patient factors such as gender, age and underlying disease, the imaging pattern of the hematoma at admission, the use of antithrombotic drugs, the mode of anesthesia, different surgical procedures, and adjuvant medications.
Key words:  chronic subdural hematoma  recurrence  risk factors  surgical procedures  drugs